Digital Health

FDA approves AGENT DCB for coronary artery disease patients

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary...
- Advertisement -spot_img

Latest News

Bruins need these five players to step up after Montgomery’s firing

The Boston Bruins' awful start to the 2024-25 NHL season cost head coach Jim Montgomery his job, and now...
- Advertisement -spot_img